Transplant decision making in myelofibrosis with myeloid metaplasia.

Low-risk disease is defined by the absence of hemoglobin < 10 g/dL, circulating blasts, and severe constitutional symptoms. The presence of one or more of these features define intermediate-risk and high-risk disease, respectively.⁵⁴